Sunday, December 22 2024

Shawnee officials OK rezoning request for new townhomes

firststargroup June 17, 2022

Boston Properties buys 50% interest in a pair of vacant Herndon office buildings

firststargroup April 26, 2023

M&A Roundup: Capstreet, Bluestem Equity, others announce deals

firststargroup January 14, 2023

Four things to watch for in the economy for businesses in 2023

firststargroup January 6, 2023

Oregon ramped up funding for access to abortion care before SCOTUS leak

firststargroup June 9, 2022

Newly built Clarence home sells for $6.5 million, setting new record

firststargroup August 11, 2022

Plumb Oyster Bar in downtown Troy has closed

firststargroup October 22, 2022

U.S. Bank, Wells Fargo, PNC join push to form Apple Pay, PayPal competitor

firststargroup January 25, 2023

Nausea no more? D.C. biotech gets motion sickness drug to next stage.

firststargroup July 18, 2019

The company’s latest experimental drug was tested on more than 100 patients with motion sickness traveling on the Pacific Ocean.

About the author

firststargroup

Suggested Posts

Podcast: How Quang Pham pulled off BioFlorida’s deal of the year

Construction company doubles its Denver footprint with new lease on Platte Street

Sacramento still processing permit for California Northstate University teaching hospital project

With megaprojects on the table, De Soto simplifies zoning rules for battery manufacturers

Waldo’s Chicken & Beer expands to Alabama

Grocery stores jostle for position in Phoenix metro market as Kroger-Albertsons merger looms

More Stories

Money manager opens new S.F. office, hires UBS team

firststargroup May 18, 2019